Logo image of IBM

INTL BUSINESS MACHINES CORP (IBM) Stock Fundamental Analysis

USA - NYSE:IBM - US4592001014 - Common Stock

312.57 USD
-0.52 (-0.17%)
Last: 10/28/2025, 8:04:00 PM
312 USD
-0.57 (-0.18%)
Pre-Market: 10/29/2025, 5:08:28 AM
Fundamental Rating

4

Overall IBM gets a fundamental rating of 4 out of 10. We evaluated IBM against 85 industry peers in the IT Services industry. While IBM belongs to the best of the industry regarding profitability, there are concerns on its financial health. IBM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

IBM had positive earnings in the past year.
IBM had a positive operating cash flow in the past year.
IBM had positive earnings in each of the past 5 years.
Each year in the past 5 years IBM had a positive operating cash flow.
IBM Yearly Net Income VS EBIT VS OCF VS FCFIBM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

The Return On Assets of IBM (5.40%) is better than 69.41% of its industry peers.
The Return On Equity of IBM (28.34%) is better than 92.94% of its industry peers.
IBM's Return On Invested Capital of 8.07% is fine compared to the rest of the industry. IBM outperforms 68.24% of its industry peers.
IBM had an Average Return On Invested Capital over the past 3 years of 7.07%. This is significantly below the industry average of 27.89%.
The last Return On Invested Capital (8.07%) for IBM is above the 3 year average (7.07%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.4%
ROE 28.34%
ROIC 8.07%
ROA(3y)3.74%
ROA(5y)3.83%
ROE(3y)20.94%
ROE(5y)24.07%
ROIC(3y)7.07%
ROIC(5y)6.14%
IBM Yearly ROA, ROE, ROICIBM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

The Profit Margin of IBM (12.09%) is better than 87.06% of its industry peers.
IBM's Profit Margin has declined in the last couple of years.
The Operating Margin of IBM (16.06%) is better than 84.71% of its industry peers.
In the last couple of years the Operating Margin of IBM has remained more or less at the same level.
IBM's Gross Margin of 57.81% is fine compared to the rest of the industry. IBM outperforms 78.82% of its industry peers.
IBM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.06%
PM (TTM) 12.09%
GM 57.81%
OM growth 3Y10.6%
OM growth 5Y0.28%
PM growth 3Y-1.4%
PM growth 5Y-10.1%
GM growth 3Y1.05%
GM growth 5Y0.73%
IBM Yearly Profit, Operating, Gross MarginsIBM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IBM is destroying value.
IBM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IBM has more shares outstanding
The debt/assets ratio for IBM has been reduced compared to a year ago.
IBM Yearly Shares OutstandingIBM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
IBM Yearly Total Debt VS Total AssetsIBM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

IBM has an Altman-Z score of 3.59. This indicates that IBM is financially healthy and has little risk of bankruptcy at the moment.
IBM has a Altman-Z score of 3.59. This is comparable to the rest of the industry: IBM outperforms 60.00% of its industry peers.
The Debt to FCF ratio of IBM is 5.27, which is a neutral value as it means it would take IBM, 5.27 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IBM (5.27) is comparable to the rest of the industry.
IBM has a Debt/Equity ratio of 1.98. This is a high value indicating a heavy dependency on external financing.
IBM's Debt to Equity ratio of 1.98 is on the low side compared to the rest of the industry. IBM is outperformed by 77.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.98
Debt/FCF 5.27
Altman-Z 3.59
ROIC/WACC0.92
WACC8.79%
IBM Yearly LT Debt VS Equity VS FCFIBM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

IBM has a Current Ratio of 0.93. This is a bad value and indicates that IBM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.93, IBM is doing worse than 82.35% of the companies in the same industry.
A Quick Ratio of 0.89 indicates that IBM may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.89, IBM is doing worse than 82.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.89
IBM Yearly Current Assets VS Current LiabilitesIBM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

IBM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.71%.
Measured over the past years, IBM shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.21% on average per year.
IBM shows a small growth in Revenue. In the last year, the Revenue has grown by 4.51%.
The Revenue has been growing slightly by 1.69% on average over the past years.
EPS 1Y (TTM)6.71%
EPS 3Y1.19%
EPS 5Y-4.21%
EPS Q2Q%15.22%
Revenue 1Y (TTM)4.51%
Revenue growth 3Y3.05%
Revenue growth 5Y1.69%
Sales Q2Q%9.11%

3.2 Future

The Earnings Per Share is expected to grow by 6.21% on average over the next years.
Based on estimates for the next years, IBM will show a small growth in Revenue. The Revenue will grow by 4.94% on average per year.
EPS Next Y8.82%
EPS Next 2Y7.9%
EPS Next 3Y7.12%
EPS Next 5Y6.21%
Revenue Next Year6.33%
Revenue Next 2Y5.38%
Revenue Next 3Y5.05%
Revenue Next 5Y4.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IBM Yearly Revenue VS EstimatesIBM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B
IBM Yearly EPS VS EstimatesIBM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 28.49, which means the current valuation is very expensive for IBM.
IBM's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.00. IBM is around the same levels.
A Price/Forward Earnings ratio of 25.99 indicates a quite expensive valuation of IBM.
IBM's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, IBM is valued at the same level.
Industry RankSector Rank
PE 28.49
Fwd PE 25.99
IBM Price Earnings VS Forward Price EarningsIBM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

IBM's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as IBM.
Industry RankSector Rank
P/FCF 24.32
EV/EBITDA 21.91
IBM Per share dataIBM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IBM does not grow enough to justify the current Price/Earnings ratio.
IBM has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.23
PEG (5Y)N/A
EPS Next 2Y7.9%
EPS Next 3Y7.12%

5

5. Dividend

5.1 Amount

IBM has a Yearly Dividend Yield of 2.15%.
IBM's Dividend Yield is rather good when compared to the industry average which is at 2.50. IBM pays more dividend than 90.59% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, IBM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.15%

5.2 History

The dividend of IBM has a limited annual growth rate of 0.81%.
IBM has been paying a dividend for at least 10 years, so it has a reliable track record.
IBM has decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.81%
Div Incr Years2
Div Non Decr Years2
IBM Yearly Dividends per shareIBM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

78.75% of the earnings are spent on dividend by IBM. This is not a sustainable payout ratio.
The dividend of IBM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP78.75%
EPS Next 2Y7.9%
EPS Next 3Y7.12%
IBM Yearly Income VS Free CF VS DividendIBM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B
IBM Dividend Payout.IBM Dividend Payout, showing the Payout Ratio.IBM Dividend Payout.PayoutRetained Earnings

INTL BUSINESS MACHINES CORP

NYSE:IBM (10/28/2025, 8:04:00 PM)

Premarket: 312 -0.57 (-0.18%)

312.57

-0.52 (-0.17%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)10-22 2025-10-22/amc
Earnings (Next)01-27 2026-01-27/amc
Inst Owners65.04%
Inst Owner Change0.02%
Ins Owners0.09%
Ins Owner Change0.85%
Market Cap291.17B
Revenue(TTM)65.40B
Net Income(TTM)7.91B
Analysts69.63
Price Target286.2 (-8.44%)
Short Float %1.7%
Short Ratio3.08
Dividend
Industry RankSector Rank
Dividend Yield 2.15%
Yearly Dividend6.68
Dividend Growth(5Y)0.81%
DP78.75%
Div Incr Years2
Div Non Decr Years2
Ex-Date11-10 2025-11-10 (1.68)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.08%
Min EPS beat(2)4.89%
Max EPS beat(2)7.28%
EPS beat(4)4
Avg EPS beat(4)7.18%
Min EPS beat(4)3.59%
Max EPS beat(4)12.97%
EPS beat(8)8
Avg EPS beat(8)5.75%
EPS beat(12)11
Avg EPS beat(12)5.17%
EPS beat(16)15
Avg EPS beat(16)4.03%
Revenue beat(2)2
Avg Revenue beat(2)0.92%
Min Revenue beat(2)0.5%
Max Revenue beat(2)1.34%
Revenue beat(4)3
Avg Revenue beat(4)0.23%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.34%
Revenue beat(8)3
Avg Revenue beat(8)-0.35%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)8
Avg Revenue beat(16)0.23%
PT rev (1m)0.1%
PT rev (3m)3.81%
EPS NQ rev (1m)-0.07%
EPS NQ rev (3m)1.16%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)2.11%
Revenue NQ rev (1m)-0.22%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 28.49
Fwd PE 25.99
P/S 4.45
P/FCF 24.32
P/OCF 21.59
P/B 10.43
P/tB N/A
EV/EBITDA 21.91
EPS(TTM)10.97
EY3.51%
EPS(NY)12.03
Fwd EY3.85%
FCF(TTM)12.85
FCFY4.11%
OCF(TTM)14.47
OCFY4.63%
SpS70.21
BVpS29.96
TBVpS-54.99
PEG (NY)3.23
PEG (5Y)N/A
Graham Number85.99
Profitability
Industry RankSector Rank
ROA 5.4%
ROE 28.34%
ROCE 9.45%
ROIC 8.07%
ROICexc 9.31%
ROICexgc 52.18%
OM 16.06%
PM (TTM) 12.09%
GM 57.81%
FCFM 18.31%
ROA(3y)3.74%
ROA(5y)3.83%
ROE(3y)20.94%
ROE(5y)24.07%
ROIC(3y)7.07%
ROIC(5y)6.14%
ROICexc(3y)8.07%
ROICexc(5y)6.94%
ROICexgc(3y)39.64%
ROICexgc(5y)31.12%
ROCE(3y)8.28%
ROCE(5y)7.2%
ROICexgc growth 3Y23.43%
ROICexgc growth 5Y15.29%
ROICexc growth 3Y14.68%
ROICexc growth 5Y5.67%
OM growth 3Y10.6%
OM growth 5Y0.28%
PM growth 3Y-1.4%
PM growth 5Y-10.1%
GM growth 3Y1.05%
GM growth 5Y0.73%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 1.98
Debt/FCF 5.27
Debt/EBITDA 3.6
Cap/Depr 31.23%
Cap/Sales 2.31%
Interest Coverage 250
Cash Conversion 87.87%
Profit Quality 151.41%
Current Ratio 0.93
Quick Ratio 0.89
Altman-Z 3.59
F-Score6
WACC8.79%
ROIC/WACC0.92
Cap/Depr(3y)39.45%
Cap/Depr(5y)41.95%
Cap/Sales(3y)2.96%
Cap/Sales(5y)3.91%
Profit Quality(3y)291.08%
Profit Quality(5y)263.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.71%
EPS 3Y1.19%
EPS 5Y-4.21%
EPS Q2Q%15.22%
EPS Next Y8.82%
EPS Next 2Y7.9%
EPS Next 3Y7.12%
EPS Next 5Y6.21%
Revenue 1Y (TTM)4.51%
Revenue growth 3Y3.05%
Revenue growth 5Y1.69%
Sales Q2Q%9.11%
Revenue Next Year6.33%
Revenue Next 2Y5.38%
Revenue Next 3Y5.05%
Revenue Next 5Y4.94%
EBIT growth 1Y14.74%
EBIT growth 3Y13.97%
EBIT growth 5Y1.98%
EBIT Next Year72.33%
EBIT Next 3Y25.44%
EBIT Next 5Y19.31%
FCF growth 1Y3.97%
FCF growth 3Y5.46%
FCF growth 5Y-0.17%
OCF growth 1Y0.37%
OCF growth 3Y1.67%
OCF growth 5Y-1.86%

INTL BUSINESS MACHINES CORP / IBM FAQ

What is the fundamental rating for IBM stock?

ChartMill assigns a fundamental rating of 4 / 10 to IBM.


What is the valuation status for IBM stock?

ChartMill assigns a valuation rating of 2 / 10 to INTL BUSINESS MACHINES CORP (IBM). This can be considered as Overvalued.


How profitable is INTL BUSINESS MACHINES CORP (IBM) stock?

INTL BUSINESS MACHINES CORP (IBM) has a profitability rating of 7 / 10.


How financially healthy is INTL BUSINESS MACHINES CORP?

The financial health rating of INTL BUSINESS MACHINES CORP (IBM) is 2 / 10.


Is the dividend of INTL BUSINESS MACHINES CORP sustainable?

The dividend rating of INTL BUSINESS MACHINES CORP (IBM) is 5 / 10 and the dividend payout ratio is 78.75%.